COMP <GO>
RVMD vs MRNA // EV/EBITDA & P/E VALUATION
Revolution Medicines Inc. (NASDAQ) VS. Moderna Inc. (NASDAQ) • 15-METRIC TALLY: RVMD 4
— MRNA 4
■ METRIC PARITY
LAST: $191.31 (+0.55%) • MKT CAP: $40.78B
valuation
—
LAST: $221.72 (-0.47%) • MKT CAP: $88.93B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVMD VS. MRNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVMD | MRNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 55.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.60% | -34.10% | +5.50 | RVMD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.24% | -2.32% | +0.08 | RVMD | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 15.40% | -39.90% | +55.30 | RVMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 15.07 | +10.93 | RVMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 57.7 | -9.90 | MRNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 1.10 | -0.03 | MRNA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.0x | 32.0x | +2.00 | MRNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $40.78B | $88.93B | -$48.15B | MRNA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVMD REV | MRNA REV | RVMD GROSS % | MRNA GROSS % | RVMD FCF | MRNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.94B | — | 55.3% | -$913.7M | -$2.06B |
| FY 2024 | $0 | $3.24B | — | 54.8% | -$567.7M | -$4.05B |
| FY 2023 | $11.6M | $6.85B | — | — | -$351.1M | -$3.43B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVMD // BETA 1.07
MRNA // BETA 1.10